Pfizer Ends Test of Lung-cancer Drug - Wall Street Journal
Pfizer Ends Test of Lung-cancer DrugWall Street JournalPfizer Inc. said Tuesday it ended a Phase III study for an experimental lung-cancer drug called figitumumab that had been associated ...Pfizer ends late-stage lung-cancer studyReutersPfizer ends trial of lung cancer drug candidateBusinessWeekPfizer cancer drug fails in late stagesTheDay.comEarthtimes (press release)�-MSN Moneyall 33 news articles��
Blog Content
Post a Comment